These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2844089

  • 1. Safety and tolerability of lisinopril in older hypertensive patients.
    Rush JE, Lyle PA.
    Am J Med; 1988 Sep 23; 85(3B):55-9. PubMed ID: 2844089
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with lisinopril. Observations on safety and tolerability.
    Cameron HA, Higgins TJ.
    J Hum Hypertens; 1989 Jun 23; 3 Suppl 1():177-86. PubMed ID: 2550641
    [Abstract] [Full Text] [Related]

  • 3. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
    Goldberg AI, Dunlay MC, Sweet CS.
    Am J Cardiol; 1995 Apr 15; 75(12):793-5. PubMed ID: 7717281
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The safety and tolerability of lisinopril in clinical trials.
    Rush JE, Merrill DD.
    J Cardiovasc Pharmacol; 1987 Apr 15; 9 Suppl 3():S99-107. PubMed ID: 2442561
    [Abstract] [Full Text] [Related]

  • 6. Review of international safety data for lisinopril-hydrochlorothiazide combination treatment.
    Murray NH.
    J Hum Hypertens; 1991 Dec 15; 5 Suppl 2():63-7; discussion 68. PubMed ID: 1665180
    [Abstract] [Full Text] [Related]

  • 7. Duration of angiotensin-converting enzyme inhibition: implications for tolerability.
    Murray NH.
    Cardiology; 1991 Dec 15; 79 Suppl 1():22-9. PubMed ID: 1655262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lisinopril: dose-peak effect relationship in essential hypertension.
    Cirillo VJ, Gomez HJ, Salonen J, Salonen R, Rissanen V, Bolognese JA, Nyberg R, Kristianson K.
    Br J Clin Pharmacol; 1988 May 15; 25(5):533-8. PubMed ID: 2841960
    [Abstract] [Full Text] [Related]

  • 11. [Multicenter clinical study of the antihypertensive activity of lisinopril].
    Cinotti GA, Bossini A, Cagli V, Corea L, Di Veroli C, Morabito S, Pierucci A, Porcellati C, Savino K, Timio M.
    Minerva Med; 1989 Jan 15; 80(1):53-63. PubMed ID: 2536907
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lisinopril and captopril in the treatment of heart failure in older patients. Comparison of a long- and short-acting angiotensin-converting enzyme inhibitor.
    Giles TD, Fisher MB, Rush JE.
    Am J Med; 1988 Sep 23; 85(3B):44-7. PubMed ID: 2844087
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P, Dallocchio M, Gourgon R.
    J Hum Hypertens; 1989 Jun 23; 3 Suppl 1():23-8. PubMed ID: 2550642
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension.
    Zachariah PK, Bonnet G, Chrysant SG, DeBacker G, Goldstein R, Herrera J, Lindner A, Materson BJ, Maxwell MH, McMahon FG.
    J Cardiovasc Pharmacol; 1987 Jun 23; 9 Suppl 3():S53-8. PubMed ID: 2442553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.